Observational study of severe acute respiratory infections
Official title: Short Period Incidence Study of Severe Acute Respiratory Illness
Run by Australian and New Zealand Intensive Care Research Centre · NCT02498587 · Data updated 2026-11-12
This study is trying to learn more about severe respiratory infections in hospitalized patients during winter to help prepare for future outbreaks.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 15000 (estimated) |
| Sponsor | Australian and New Zealand Intensive Care Research Centre Academic / other |
| Locations | 1 site (Melbourne, Victoria) |
| Status | Recruiting |
| Started | January 2016 |
| Main results expected | December 2026 |
| Study ends | December 2026 |
| Registry record updated | August 9, 2024 |
| Trial ID | NCT02498587 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include patients with recent onset fever, cough, and either shortness of breath or rapid breathing requiring hospitalization.
✕Probably not a fit
Patients without symptoms of severe acute respiratory infection or those not requiring hospitalization may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to gather data on patients with severe acute respiratory infections (SARI) admitted to hospitals and intensive care units during the winter months in both hemispheres. It will involve a 5 to 7-day cohort study across 20 to 40 participating sites globally, collecting clinical information and sample data as part of routine clinical practice. The primary goal is to establish a research response capability for future epidemics or pandemics, while the secondary aim focuses on understanding the epidemiology and microbiology of SARI.
Why it matters
Potential benefit: If successful, this study could enhance preparedness and response strategies for future respiratory infection outbreaks.
How similar studies have gone: Previous observational studies on SARI have been crucial for understanding outbreaks, indicating that this approach has been effective in the past.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * A history of feverishness or measured fever of ≥ 38 deg C; * Cough; * Dyspnoea (shortness of breath) OR Tachypnoea. Exclusion Criteria: • No exclusion criteria
Where it's running
-
Australian and New Zealand Intensive Care Research Centre
Melbourne, Victoria, Australia Recruiting
Study contacts
- Study coordinator: Nicole Ng, MBBS
- Email: mnhs-sprint.sari@monash.edu
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Effects of neuromuscular blocking agents and prone positioning on ARDS
This study tests if using certain medications and positioning patients on their stomachs can help people with severe breathing problems from ARDS survive better while on a ventilator.
-
Clinical Multimodal Surveillance of Respiratory Pathogens
This nationwide study tests a hospital-based system to track respiratory pathogens in patients with respiratory symptoms and to use samples collected during care to spot trends and support prevention efforts.
-
CRP point-of-care testing to guide antibiotic use for adults with respiratory symptoms in eight Jakarta primary care centers
This trial tests whether using a C-reactive protein point-of-care test can help doctors in Jakarta decide when antibiotics are needed for adults with acute respiratory infections.
-
Observational study on acute respiratory infections in primary care across Europe
This study looks at how acute respiratory infections are treated in adults and children visiting primary care in Europe to help improve care and support future research.
-
Observational study of acute respiratory infections in adults
This study looks at how adults with acute respiratory infections are treated in hospitals across Europe to see what works best and improve patient care.
-
National guideline program to reduce unnecessary antibiotics for colds and flu-like illnesses in Swiss primary care
This project will test whether training family doctors to use new Swiss guidelines, point-of-care CRP testing, and shared decision-making can reduce unnecessary antibiotic prescriptions for adults with acute respiratory or flu-like illnesses in primary care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.